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A mixture of the aliphatic alcoho l, triacontanol , and other 
chemically associated natura lly occurring alcohols was ap-
plied to the denuded dorsal cutaneous surfa ce of g uinea 
pigs to evaluate anti-inflammatory activity . III the setting 
of a chemical irritation w ith 2% croton oil and in an allergic 
dermatitis created w ith dinitrochlorobenzene sens iti za tion 
and cha lJ enge, the tri acontanol-containin g preparation w as 
signifi cantly more effective than vehicle alone (OHL skin 
cream) but not as effective as 0.05% Oiprolene® ointment. 
T he need ex ists fo r nonsteroid-based anti-inAamm atory skin preparations. Po tent hal ogenated steroid com-pounds commonly Ll sed today ca nnot be applied sa fely to facia l skin , and arc occasionall y absorbed into areas where th ey arc systemi ca ll y active. Man y naturall y 
occurring prepa rations have been sought- for th eir repo rted me-
dic in al va lues, only to be found ineffecti ve in controll ed studies. 
One such naturall y occurrin g co mpound, tria contanol , is rela-
tively ubiquitous in plant products and has been known to be 
effective as a plant growth regulator for m any yea rs [1 ,2]. As 
th ese co mpounds arc regul arl y in ges ted in our diets and deemed 
sa fe by regulatory agencies , limited studies ha ve been condu cted 
in hum ans. Preliminary studies in hum ans indi ca ted potenti al anti -
inAaml11 ato ry and anti-Herpes Simplex properties w hen applied 
topi ca ll y (personal observations , L. L. C lark , 1981-1986) , and 
pro mpted this anima l stud y to eva luate efficacy in controll ed 
tri als. 
C hemicall y, triacontanol is a 30-ca rbon alcohol, present in sig-
nifi cant concentrations in beeswax, and associated with multiple 
contaminatin g fatty acid esters and other free acids [31. It has a 
so lubility of < '10 - 1(, molar in aqueou s media , is onl y slightly more 
soluble in ethanol , but has excellent lipid solubility 14,51. Previous 
studies in plants have utilized suspensions of triacontanol to cir-
cum vent this problem ofrclative water insolubility and have been 
successful. Res ults of earl ier anim al studies (unpublished data) 
suggest that these tria contanol-containin g co mpo unds possess 
moderate anti-inAamm atory activity. This stud y was undertaken 
to eva lu ate the effectiveness of a mi xture of these co mpo unds in 
Manuscript rcceived Apri l II , 1986; accepted for publ ica tion December 
I, '1986. 
I~cprint requests to: Paul T. McBride, M. D. , NIH / NIAID , Building 
10, Room ll-N-228, Bcthesda , Maryland 20892. 
Abbrcviations: 
DNCB: dinitrochlo robenzcnc ( l-chloro-2,4-dinit robcnzcne) 
DN FB: dillitroAuorobcnzcnc (1-Auo ro-2, 4-dillitrobcnzene) 
PBML: peripheral blood mononuclea r leukocytes 
Lymphocyte stimulatio n was studied by tritiated th ymi-
dine uptake and morpho logic exam ination for blast trans-
formation. When triacontanol-containing compounds were 
so lubili zed in aqueous mcdia, effects on lymphocytes were 
insignifi cant. When solubilized in ethanol, there was a marked 
effect on thymidine uptakc but not on blast transfo rmation 
w hen co mpared to parallel controls. J Jll llcst DCI'II/atol 89: 
380-383, 1987 
d imini shin g inAammatio n und er controlled co nditions , and to 
co mpare their effi cacy w ith that of es tablished contro ls. 
MATERIALS AND METHOD S 
Experimental Animals H artley strain , o utbred , fem ale albi no 
guin ea pigs, 350-400 g each, were obtained fro m C harles Ri ver 
Breedin g Labs, Wilmington, M assachusetts. The animal s werc 
stored 6 per cage with ample access to fo od and water. To rcmove 
dorsa l hair, the an imals we re anesthet ized w ith sod iull1 pento-
barbital (Veterinary Labo rato ri es, Lenexa, Kan sas) at a dose of 
0.25 mg/kg of body weight via i. p. injection. An Oster m odel 
A-5 anima l clipper (Oster In c., Mil waukce, Wisconsin) was used 
to "close clip" each animal 16- 9]. Thi s was fo ll owed by 2 se-
quential1 O-min applica tions of the chemical depilatory Nair (Carter-
Wallace, New Y o rk, N ew York) to residual dorsa l hair aftcr 
wetting with tap wa ter. The N air was rem oved by tap water 
wash in g after each applica tion. The denu ded skin surfa ce w as 
washed well fo llowin g the seco nd app li cation and each anim al 
was towel dried . Test areas were dem arca ted usin g a black lab-
o rato ry m arker, and the anim als were returned to the cage for 
24 h befo re inAall1mation was induced 11 0 1. Each anim al had 5 
test areas o utlin ed in the delluded area to allow simultaneous 
evaluation o f 5 pharm aco logic trea tm ent regimens. 
Chemicals and Reagents DinitroAuo robell zene (DNFB), (1-
Au oro- 2,4-dinitro bcnzene) and dinitrochlorobenzene (D N CB) 
(1-chloro-2,4-dinitrobenzene) were obtained from Eastman 
C hemica ls, Rochester, N ew York. Acetone and rea gent alco hol 
were obtained fro m Ameri can Scientific Produ cts, M cGaw Park , 
Illino is. C roton oil was obtained from Sig ma C hemical Co. , St. 
Lo uis, Missouri. Triacontanol-containillg co mpounds and DHL 
skill crea m (both proprietary compounds) were obtained from 
Royal Pharmaceuticals, Bountiful , Utah, as ex perimental drug 
for evaluat ion as 1 % and 5% (weight triacontanol com-
pound/weight DI-IL vehicle) concentrat io n suspensions. T hese 
triacontano l-containing co mpo unds were prepared by Dr. Sidney 
A. Williamson (Departm en t of Chemistry , Uni versity o f Utah 
Sa lt Lake C ity, U tah); they contained 16.7% 28-ca rbon alco hol, 
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66.6% 30- carbon alcoho l, and 16.6% 32-ca rbon len g th alcoho l 
components. Mixture purity o f > 99. 9% was ve rifi ed b y gas chro-
matog raphy prior to usc in this study. The D HL vehi cle and 
triacontanol- containin g suspensio ns were prepared b y Dr. Robert 
Petersen (Un iversity of Utah College of Pharmacy, Sa lt Lake 
C Ity, Utah). T riacon tanol was blended into suspension on a pro-
portional weight basis w ith vehicle. Constituents of the D HL 
v ehicle are listed by percentage of to tal co mpound weight: water 
~4.7%, isopropyl m yristate 22.0%, g lycero lm onostea rate 6.0%, 
Isopro pyl lano late 5.0%, t ri acontano l co mpo und 5.0%, pro pyl-
ene g lycol 5.0%, triethano lamin e 1. 3%, and Ge rm abcn-II @ 1.0% 
(Sutton Labs , Inc.). T he blending process consisted of a 2-com-
ponent liquifi ca tion at 75°C, liquid phase mi xing, then continu ous 
m lx ll1g w hile return ing to a crea m base preparation at roo m telll -
peraturc. Oiprolene® ointmcnt 0.05% was obta ined from Scher-
ing Corpo ration , Kenilworth , N cw J ersey . rJH]Th ymidin e (6.7 
Ci/mlllo l) was o btain cd from N ew England Nu clear, Boston , 
Massachu setts. 
Treatment Regimen Each anim al was subjected to 5 modes 
of treatm ent consistin g of: . (l ) no trea tment; (2) vehicle alone 
(D HL sk in crea m) ; (3) 1 % tria contanol suspensio n in DHL ve-
h icle; (4) 5% tria con tano l suspension in D HL vehicle; and (5) 
Diprolene® ointment 0.05%, a very potent top ical co rticos teroid 
known to be effect ive in depress in g sk in infl amlll ation . Approx-
Ima tely 250 mg of each co mpo und was administered 3 tim es/day 
by manu all y rubbing th e d ru gs on to each of the respective tes t 
a reas. T he anim als were iso lated one to a cage. T he g uinea pi gs 
:vere examin ed dai ly by a sing le-bli nd ed expert observe r, and 
m fl amm ationlirritati on were recorded qua litatively utili zin g a 1 + 
(no erythem a) to 4 + (severe erythem a/ untreated contro l area) 
sco ring sys tem for each tes t area. Nair was aga in app lied (for 4-
min durat ion on ly) on day 4 of therap y to return the skin to a 
denuded condition and ex pedite reading of erythem a. 
Allergic Sensitization Each of 12 experim enta l anim als had 
the hai r removed fro m th eir ri g ht flank area via close clipping 
w ithout anesthesia. Sensitiza ti on was acco mplished usin g to pica l 
application of 10% DNFB in acetone (vol/vol) onto the clipped 
ri g ht fl ank area via drippin g th e solution onto the skin from a 
g rad uated 1.0 m l syrin ge (Pharmasea l Laboratori es, Glend ale, 
Ca lifornia) and isolatin g the anim als fo r 20 min to allow solvent 
evaporatio n. At 4 da ys the anim als were chall enged w ith 0.02 ml 
of5% DN C B in aceto ne (wt/ vo l) app lied to th e left ea r to verify 
sensitiza tion . A dose- response curve for DN C B in acetonc 
(0. 1 % -5.0%) was perfo rmed on the le ft ear of5 sensiti zed anim als 
to determ ine the concent ration of ON CB yieldin g the optimal 
s tate o f contact sensiti za tion on visual inspecti on 24 h later. T he 
anima ls were subsequently chaLlenged wi th a 2% D N CB so lution 
delivered as 0.2 m l aliquo ts onto each o f the 5 out lined test arcas 
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(tota l volum e of 1.01111) from a 1.0 m l sy rin gc. Two hours after 
receiving th e chall enge dose, thc an im als were starrcd on the 
treatment regimcn ou tlined above. 
Skin Inflammation From Chemical Irritation Each of 12 
experim enta l anim als w ith denuded do rsa l areas was t reatcd with 
a 2% so lutio n of croton o il in acetone/ethan ol (70% /30%). T hc 
cro to n o il was delive red to the skin via a 1.0 m l sy rin ge, 0.2 ml 
to each tes t arca, as described above. T reatmcnt was initiated 2 
h afte r app lica tion of th e irritant so luti on , and each an im al was 
exa min ed dail y as described above. 
Human Lymphocyte Blast Transformation Human pe-
riph eral blood mo nonuclear lymphocytes (PBM L) were obtained 
from health y don o rs utilizing sta nd ard sy rin ge vcni puncture tech-
niquc. A total of35-40 m l of blood was obtained and heparin izcd 
usin g commerciall y avai lab lc sod ium heparin (Elkins-Sinn In c. , 
C herr y Hi ll , N ew J ersey). Blood was mi xed in a 1:1 ratio w ith 
RPM I 1640 tissue culture m cdia (G IBCO Labo rato ries , Grand 
Island , N ew York), laye red o nto a "cushio n" of Ficoll- Paque® 
(Pharmacia In c. , Pisca tawa y, N ew J ersey) and centrifuged in a 
Beck m an M odel TJ-6R refri gerated centrifuge (Beck man Instru-
mcnts, Palo Alto, Ca lifo rni a) for 45 min at 1200 rpm and 4°C 
1111 . T he cel l pellet was resuspended in 5.0 1111 of RPMI 1640 
med ia containing 10% feta l bovine se rum and countcd uti lizin g 
trypan bluc excl usio n techniques in a 0. 1 III I N eubauer type he-
macytomcter (A mcrica n Optica l, Bu ffalo, N ew York) . C ells, 0. 1 
m l at 2 x 106/ m l werc transferred to a Falcon M odcl 3072 96 
we ll fl at botto m mi crotcst plate (Bccto n Dickin son Labware, Ox-
na rd , Ca liforn ia) . So lutions o f pure tr iacontano l co mpoun d werc 
obtained by: (1) serial d il uti ons of "saturated " stock solution (250 
m g of tria contanol preparation stirrcd in '10 m l o f HPM I tissue 
culture media fo r 48 h) fo ll owed by vigo ro us centrifu ga tion and 
fi lter steriliza tion; and (2) dissolvin g I 00 m g o f t riacontano l prep-
arati on in 10 ml of absolute ethanol, fd ter steri lizin g, and addin g 
va rying vo lumes to RPM I tissue culture m edia . Con trols and 
varying conccntrat ions of triacontano l co mpounds were studied 
in thc prcsence and abscnce of PH A (phytohem agg lutinin) usin g 
standard methodo logies. Blast transfo rm at io n was meas urcd by 
quantitati ve lymph ocyte countin g and co rrelated w ith 
rJH ]thy midinc uptake at 48 h . 
RESULTS 
All 24 anim als were subjected to thc same therapeutic mod alities 
and werc eva luated on a daily bas is to determ inc efficacy of ex-
perimentall y trea ted vs control arcas. T rea tm ents werc perfo rm ed 
with vehicle and test preparati ons simu ltan eously, and ex peri-
mcntal t rea tm cnt areas werc varied am o ng the anim als betwccn 
pos iti ons o n the backs to minimi ze cffects of region al var iat io ns 
on treatm ent results. All anim als in both the cro ton o il irritation 
Tab le I. Signifi cance of D HL Vehiclc, 1 % Triacontanol, 5% Triacontanol , and 0.05% Dipro lene O intment Trcatment Regi mcns 
Aga inst Contro l 
Day 
I 
2 
3 
4 
5 
6 
7 
1 
2 
3 
4 
5 
6 
7 
Regimen 
Croton oil 
Croton oil 
C roton oi l 
C roton oil 
Croton oil 
Croton oil 
C roton oil 
DNCB 
ONCB 
ONCB 
ON CI3 
ONCB 
ON C13 
ONCB 
OHLIControl 
.0679-' 
.0679 
.0431 
.0 I SO 
.0277 
.011 7 
.0022 
.0 1S0 
.0117 
.0077 
.0033 
.0277 
.0679 
.0 180 
ONCE = dillitrochlorobcllzcllc ( l-chloro-2.4-d illitrobcll zc ll c) 
1% T riaconta nol/Control 
.043 1 
.0ISO 
.01 17 
.0077 
.0077 
.005 1 
.0022 
.0 1S0 
.0 180 
.0 ISO 
.0022 
.0 11 7 
.0 11 7 
.0077 
"p va luc: cx pcrirn clHa l trC3 [Ill Cfl( vs contro l (c;dcubtcd via \Vilcoxon signed-rank J Il Jlys is). 
5% TriacontJnol/Control DiprolenclControl 
.0077 .0022 
.0 117 .0022 
.0033 .0022 
.0033 .0022 
.005 1 .0022 
.005 1 .0022 
.0022 .0022 
.0117 .0022 
.0077 .0022 
.0033 .0022 
.0022 .0022 
.0022 .0022 
.0077 .0022 
.0033 .0022 
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Table II. Sig nifi ca nce of 1% Triacontano l, 5% Triacontanol , and 0 .05% Oiprolene Treatment Regim cns Versus OHL 
Vehi clc Alo ne 
DJ Y Regimcn 1% TriJColltJnol/ DH L 5% T riacontJnoll DHL Diproknc/ DHL 
Croton oi l .6858" '()43 I .()(l22 
2 C; roton oil .4630 .2249 .0033 
3 Croton oi l . )422 .0 180 .0022 
4 Croton oil .0679 .0077 .U()22 
5 Croton oil .1 422 .0935 .0022 
(, Croton oi l . 1422 .0(,30 .0022 
7 Croton oi l .IOSR .2076 .O(l22 
I DNC13 .685H 1. 0000 .(J033 
2 DNC U .(,858 1.0000 .0033 
3 DNCB .2076 .7794 .0 180 
4 DNC13 .36 13 .f)! 17 .0022 
5 DN C B . 1088 .0 ) 17 .0022 
6 DN CE .0679 . 1386 .0033 
7 DN C B . 1797 .0759 .0033 
DN C I3 = di l1it rochl orobcl1 zcnc ( l-chl oro-2,4-d il1ilrobcl1 zc l1C) 
"p va I w ... ·; cxpc rimcllral trca fl11 CIH vs ve-hi ck alo ne (c:dclIl :w.:d vi:1 \'Vi lcoxoll signcd-r:lIlk :1llal ys is). 
g ro up and the ON C 13 sensiti za tio n g ro up developed m oderate to 
severe skin res po nses after app li cation of either irritant prepara-
tio n . Each experim ental treatm ent reg im en bega n 2 h after skin 
challenge wi th the res pecti ve scnsitiz in g compound, and contin-
ued 3 times/day fo r 7 days . 
All treatment pro toco ls (O HL vehicle, 1 % and 5% tri acon-
tanol, and Diprolene® o intment) we re sta tisti ca ll y sig nifi cant with 
res pect to contro l w ith p < 0.07 fo r all 7 days tested (Table I) . 
In skin dose-respo nse to lerance tri als, D H L vehicl e alo ne showed 
o bj ec ti ve erythema in the absence of previo us chemi ca ll y indu ced 
irritati o n (unpubli shed data). Despite this fact , DHL ve hicle was 
still sig nifi cantly better than no trea tment in all studies; th erefo re, 
all furth er studies compared ex pcrim cntal results w ith DHL ve-
hi cle' alo ne (T able II ). Ave raged erythem a sco res for each treat-
m ent regim en o n a dai ly bas is are pl o tted in Figs I and 2. Althou gh 
not appa rent from th e data, the cl in ical seve rity of the skin in-
Aammation o n ea ch anim al was the m ajo r determin ant of efficacy 
in all treatment regim ens. 
Summ ary analys is shows that the 1 % t ri acontano l-con ta inin g 
co mpo un d was statistica ll y better V) < 0. 10) than vehi cle alo ne 
o n l of 7 test days fo r both DNCB an d croto n o il g roups. The 
difference betwccn vehi cle and 5% triacontano l co mpo und was 
sig nifi ca nt V> < 0. 10) for 5 o f 7 days in th e croton o il arm and 3 
of 7 lb ys in the DNCB arm of th e stud y. In a few anim als, the 
5% triacon tanol co mpo und appeared to be almost as effecti ve as 
the Diprolene® ointment in bo th the cro ton o il and DNcn groups. 
Dipro lenc® o intment was clea rl y the m os t effective treatment 
regimcn w ithin the statistica l limits of this sm all stud y 0; < 0.0022). 
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Figure 1. GrJdcd ery thcnn sco res: Jllcrgic DN C B model. 
7 
Due to the nature o f th e ex perim ental protoco l, as the com rol 
arcas bega n to improve spo n tanco usly th e absolute difference 
between test and contro l areas beca m e less . T his m ade eva lu ations 
past 7 da ys difficu lt beca use all trea tm ent area scores bega n to 
app roach the sco re of the contro l area, w hi ch had arbitraril y been 
set at 4 + for each dail y observatio n. Reference to untreated nor-
m al skin was diffi cult to quant itat ive ly separate from Diprolcne<lS 
trea ted skin , and yielded no add itio nal info rm atio n . 
Lymphocy tc stimul atio n was studied by IJH Ith y midine uptake 
and m o rpho logic blast transfo rm ati o n . Purificd triacontanol com-
po und containing mixed 28- , 30- , and 32- ca rbon alcoho ls is only 
poorl y soluble in wa ter « 10- I('M) , and o ften form s suspension 
o r crys talli zcs o ut o f so luti o n w hen pl aced in aq ueous m edia. N o 
characte ri za tion of thcse soluti o ns was attcmpted to defin e the 
state of the tri acontan o l in th em , but w hen dissolved to ma xi mu m 
so lubility ill RPM I 1640 tissue culture m edia , there were no de-
m o nstrable effects o n lymph ocytes in ti ssue culture. Tri acolltanol 
co mpo un d disso lved in eth ano l and thcn added to lymphocyte 
ill tissue culture had a m arked effect 0 11 th ymidin c uptake, but 
vcry li ttle effect 0 11 bl ast tran sformation . It is un clear w hether 
this reAects lymphocyte ac ti va ti o n or ce llular dam age, but ethanol 
co ntro ls had 11 0 similar effects w hen utili zed alo ne (Table Ill ) . 
DIS C USSION 
T hc present studies ha ve co mpared th e anti-inAamm atory efficacy 
o f 2 tria colltano l-containill g co mpo und s with 0.05% Dipro lene 
o intmcl1t lI s in g 2 inA amm ato ry processes 0 11 the dorsa l skin of 
g uin ea pi gs as a mode!. Thc tri acontano l co mpo llnd s wcre clearly 
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Table Ill. Ly mphocyte Transform atio n Assay 
Regimen 
Media 
M edia / PHA 
Triacontanol media I : I 
Triacontanol media 1 : 10 
T riacontanol media 1: 100 
Triacontanol media 1: 1000 
Triacontanol ethanol 1 % 
Triacontanol ethanol 0.1 % 
Ethanol/ media 1 % 
Ethanol/media, PHA 
PHA = phyto hem agglutinin 
Percent Blast 
Transformation 
4.0 
76.0 
6.0 
5.0 
6.0 
5.0 
7.0 
5.0 
6.0 
66.0 
[3HJTh ymidine Uptake 
(cpm) 
488 
1744 
512 
526 
533 
509 
2822 
1822 
552 
1811 
no t as acti ve as Dipro lene® in anti-inflammato ry potency, but the 
5% suspension was statis tically superi or to DHL vehicle alone. 
The possib ility that DHL vehicle m ay cause mild ery thema is 
a lso of interes t sin ce use of the DHL vehicle was statistically better 
than the no treatment control in both allerg ic and chemi cal irri-
tat ion ex periments. 
There is no way, from these data, to determine the relati ve 
potency of these triacontano l compounds as anti-inflammatory 
agen ts, but it would appea r that they possess anti-inflamm ato ry 
activity . The method of action is also unknown at this point, but 
higher concentrations of triacontano l com po unds dissolved in 
e thanol seem to be lymphocyte inducers o r cause moderate dam-
age to the cells necessitating DNA repair activ ity. T his lympho-
cy te acti va tio n m ay be more impo rtant in vivo sin ce triacontanol 
is l ipid so lubl e and co uld achieve hig her concentrati o ns in non-
aq ueous environments. 
T riacontan o l and the associated es terS, alcohols, and free acids 
tha t often contamin ate the natural preparations are very diffi cu lt 
to solubilize because of the waxy constituency of the co mpounds. 
This produced the maj o r limiting factor in delivery of these chem -
icals to the skin . The 1 % prepara tio n was relati vel y easy to rub 
into the sk in , but the 5% preparatio n was no t. Applicatio n o f the 
50/0 preparation always resulted in a pas te-like layer on the surface 
o f the skin , and penetration of the entire aliquot was do ubtful. 
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Improvem ent of the vehicle to allow easier application and less 
irritation m ay also in crease the relative po tency o f these com-
po unds. 
The need exists for po tent anti-inflammatory agents without 
th e side effects of corticosteroids. Results of the current s tudies 
sugges t that triacontanol-containing mi x tures may represent such 
an alternative class of drugs. Further studies w ill be necessa ry in 
order to defin e optimal formulations, doses, and application in-
tervals fo r use of triacontanol-containin g mi x tures as nonste roidal 
anti-inflammatory preparations . 
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